Companies to lose 800 pharmaceutical jobs in New Jersey

BRIDGEWATER, KENILWORTH, NEW BRUNSWICK, and PARSIPPANY, N.J. Pharmaceutical companies in the state of New Jersey are about to make cost-cutting moves that will result in over 800 jobs being lost or transferred elsewhere, according to the Associated Press.

Schering-Plough and Johnson & Johnson had already announced the move in prior restructuring announcements, but they finally announced how many jobs would be affected. Schering-Plough will be cutting 500 jobs, while 22 jobs at J&J’s Ortho Biotech unit will be cut, and another 260 will be shifted to its Centocor unit in Pennsylvania. J&J will also cut another 267 jobs at its Ortho Biotech units outside of New Jersey. The results will be Centocor and Ortho Biotech consolidating their operations.

Abbott Laboratories has also announced that it will be cutting 83 jobs.

The cuts and transfers will begin to take effect in August.